نتائج البحث - David R. Fogelman

تنقيح النتائج
  1. 1
    Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors

    Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors حسب James C. Yao, Alexandria T. Phan, Kenneth R. Hess, David R. Fogelman, Carmen Jacob, Cecile G. Dagohoy, Colleen Leary, Keping Xie, Chaan S. Ng

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma حسب Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma

    Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma حسب Michael J. Overman, Scott Kopetz, Sijin Wen, Paulo M. Hoff, David R. Fogelman, Jeffrey S. Morris, James L. Abbruzzese, Jaffer A. Ajani, Robert A. Wolff

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants

    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants حسب Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

    Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies حسب Milind Javle, Rachna T. Shroff, Henry Xiong, Gauri Varadhachary, David R. Fogelman, Shrikanth A.G. Reddy, Darren W. Davis, Yujian Zhang, Robert A. Wolff, James L. Abbruzzese

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study

    Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study حسب Alexandria T. Phan, Daniel M. Halperin, Jennifer A. Chan, David R. Fogelman, Kenneth R. Hess, Paige Malinowski, Eileen Regan, Chaan S. Ng, James C. Yao, Matthew H. Kulke

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Home-based exercise during preoperative therapy for pancreatic cancer

    Home-based exercise during preoperative therapy for pancreatic cancer حسب An Ngo‐Huang, Nathan Parker, Xuemei Wang, Maria Q. B. Petzel, David R. Fogelman, Keri Schadler, Éduardo Bruera, Jason B. Fleming, Jeffrey E. Lee, Matthew H. G. Katz

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma

    Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma حسب An Ngo‐Huang, Holly M. Holmes, Jude K. A. des Bordes, Nathan Parker, David R. Fogelman, Maria Q. B. Petzel, Juhee Song, Éduardo Bruera, Matthew H. G. Katz

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer

    Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer حسب Jennifer B. Goldstein, Li Zhao, Xuemei Wang, Yael Ghelman, Michael J. Overman, Milind Javle, Rachna T. Shroff, Gauri R. Varadhachary, Robert A. Wolff, Florencia McAllister, P. Andrew Futreal, David R. Fogelman

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

    Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older حسب Jonathan D. Mizrahi, Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle, Rachna T. Shroff, Linus Ho, David R. Fogelman, Kanwal Raghav, Michael J. Overman, Shubham Pant

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer

    Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer حسب Van K. Morris, Michael J. Overman, Zhi-Qin Jiang, Christopher R. Garrett, Shweta Agarwal, Cathy Eng, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Robert A. Wolff, Dipen M. Maru, Scott Kopetz

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma

    Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma حسب David R. Fogelman, Elizabeth A. Sugar, George R. Oliver, Neeraj Shah, Alison P. Klein, Christine Alewine, Huamin Wang, Milind Javle, Rachna T. Shroff, Robert A. Wolff, James L. Abbruzzese, Daniel A. Laheru, Luis A. Díaz

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    <i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

    <i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma حسب Krittiya Korphaisarn, Van K. Morris, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Kanwal Raghav, Shanequa Manuel, Imad Shureiqi, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley R. Hamilton, Scott Kopetz, Arvind Dasari

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients

    Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients حسب Claudia Alvarez Florez Bedoya, Ana Carolina Ferreira Cardoso, Nathan Parker, An Ngo‐Huang, Maria Q. B. Petzel, Michael P. Kim, David R. Fogelman, Salvador Gabriel Romero, Huamin Wang, Minjeong Park, Matthew H. G. Katz, Keri Schadler

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

    Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer حسب Michael J. Overman, L. Adam, Kanwal Raghav, J. Wang, Bryan K. Kee, David R. Fogelman, Cathy Eng, Eduardo Vilar, Rachna T. Shroff, Arvind Dasari, Robert A. Wolff, Jeffrey S. Morris, Enusha Karunasena, Thomas R. Pisanic, Nilofer S. Azad, Scott Kopetz

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

    Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer حسب David R. Fogelman, Antonio Cubillo, Pilar García‐Alfonso, María Luisa Limón Mirón, John Nemunaitis, Daniel Flora, Christophe Borg, Laurent Mineur, J.M. Viéitez, Allen Lee Cohn, Gene Saylors, Albert Assad, Julie Switzky, Li Zhou, Johanna C. Bendell

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma

    Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma حسب Krittiya Korphaisarn, Van K. Morris, Jennifer S. Davis, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Arvind Dasari, Kanwal Raghav, Imad Shureiqi, Metha Trupti, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley R. Hamilton, Scott Kopetz

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

    The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy حسب Christina L. Roland, Matthew H. G. Katz, Ching‐Wei D. Tzeng, Heather Lin, Gauri R. Varadhachary, Rachna T. Shroff, Milind Javle, David R. Fogelman, Robert A. Wolff, Jean N. Vauthey, Christopher H. Crane, Jeffrey E. Lee, Jason B. Fleming

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer

    Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer حسب Seyed Pairawan, Kenneth R. Hess, Filip Janků, Nora Sánchez, Kenna Shaw, Cathy Eng, Senthilkumar Damodaran, Milind Javle, Ahmed O. Kaseb, David S. Hong, Vivek Subbiah, Siqing Fu, David R. Fogelman, Victoria M. Raymond, Richard B. Lanman, Funda Meric‐Bernstam

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer

    High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer حسب Sarah A. Bannon, Maria F. Montiel, Jennifer B. Goldstein, Wenli Dong, Maureen E. Mork, Ester Borràs, Merve Hasanov, Gauri R. Varadhachary, Anirban Maitra, Matthew H. G. Katz, Lei Feng, P. Andrew Futreal, David R. Fogelman, Eduardo Vilar, Florencia McAllister

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: